Effect of thienorphine on intestinal transit and isolated guinea-pig ileum contraction.
暂无分享,去创建一个
R. Su | Zheng Yong | Z. Gong | Yu-lei Li | Ling-di Yan | Gang Yu | Hui Yan | Pei-lan Zhou | Huajing Dong
[1] Juei-Tang Cheng,et al. Opiate-induced constipation related to activation of small intestine opioid μ2-receptors. , 2012, World journal of gastroenterology.
[2] R. N. Brogden,et al. Buprenorphine: A Review of its Pharmacological Properties and Therapeutic Efficacy , 1979, Drugs.
[3] M. Yamada,et al. Muscarinic receptor subtypes mediating Ca2+ sensitization of intestinal smooth muscle contraction: studies with receptor knockout mice. , 2010, The Journal of veterinary medical science.
[4] S. Yano,et al. Morphine leads to contraction of the ileal circular muscle via inhibition of the nitrergic pathway in mice. , 2007, European journal of pharmacology.
[5] M. Ghosh. Fundamentals of experimental pharmacology , 2007, Indian Journal of Pharmacology.
[6] J. Traynor,et al. Thienorphine: Receptor Binding and Behavioral Effects in Rhesus Monkeys , 2007, Journal of Pharmacology and Experimental Therapeutics.
[7] Z. Gong,et al. Thienorphine Is a Potent Long-Acting Partial Opioid Agonist: A Comparative Study with Buprenorphine , 2006, Journal of Pharmacology and Experimental Therapeutics.
[8] Jian-hui Liang,et al. A new buprenorphine analogy, thenorphine, inhibits morphine-induced behavioral sensitization in mice. , 2004, Acta pharmacologica Sinica.
[9] K. Schuh,et al. Pharmacokinetic comparison of the buprenorphine sublingual liquid and tablet. , 1999, Drug and alcohol dependence.
[10] Reese T. Jones,et al. Bioavailability of Sublingual Buprenorphine , 1997, Journal of clinical pharmacology.
[11] A. De Luca,et al. Insights into opioid action in the intestinal tract. , 1996, Pharmacology & therapeutics.
[12] H. Bhargava. Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome, and self-administrative behavior. , 1994, Pharmacological reviews.
[13] I. McFadzean. The ionic mechanisms underlying opioid actions , 1988, Neuropeptides.
[14] C. Smith,et al. Opioid receptors in the mouse ileum. , 1988, Archives internationales de pharmacodynamie et de therapie.
[15] J. M. Crowder,et al. Morphine inhibition of calcium fluxes, neurotransmitter release and protein and lipid phosphorylation in brain slices and synaptosomes. , 1986, Biochemical pharmacology.
[16] R. Macdonald,et al. Dynorphin A decreases voltage‐dependent calcium conductance of mouse dorsal root ganglion neurones. , 1986, The Journal of physiology.
[17] J. M. Crowder,et al. Inhibitory actions of opioid compounds on calcium fluxes and neurotransmitter release from mammalian cerebral cortical slices , 1986, British journal of pharmacology.
[18] T. Matsumiya,et al. Agonist and antagonist actions of buprenorphine on three types of opioid receptor in isolated preparations. , 1986, Japanese journal of pharmacology.
[19] R. Macdonald,et al. Dynorphin reduces voltage-dependent calcium conductance of mouse dorsal root ganglion neurons , 1984, Neuropeptides.
[20] T. Burks,et al. Centrally mediated inhibition of small intestinal transit and motility by morphine in the rat. , 1983, The Journal of pharmacology and experimental therapeutics.
[21] J. Szerb. Correlation between acetylcholine release and neuronal activity in the guinea-pig ileum myenteric plexus; effect of morphine , 1982, Neuroscience.
[22] H. Kosterlitz,et al. Stereospecific increase by narcotic antagonists of evoked acetylcholine output in guinea-pig ileum. , 1975, Life sciences.
[23] T. Burks. Mediation by 5-hydroxytryptamine of morphine stimulant actions in dog intestine. , 1973, The Journal of pharmacology and experimental therapeutics.
[24] H. Rang. STIMULANT ACTIONS OF VOLATILE ANAESTHETICS ON SMOOTH MUSCLE. , 1964, British journal of pharmacology and chemotherapy.